徕博科(LH)今日盘前大跌5.43%，引发市场广泛关注。
消息面上，尽管徕博科公布了优于预期的第二季度业绩并上调了全年利润预期，但投资者将关注点集中在其诊断实验室部门低于预期的有机增长上。该部门营收增长5.5%至29亿美元，略低于分析师预期的29.1亿美元。竞争对手Quest Diagnostics上周公布的业绩设定了更高标准，令市场对徕博科诊断业务的表现感到失望。
从整体业绩来看，徕博科第二季度总营收增长5.8%至37.3亿美元，高于预期的37.1亿美元；经调整后每股收益为4.99美元，高于预期的4.78美元。公司还将2026年每股调整后收益预期从17.70-18.35美元上调至18.10-18.55美元，中值高于分析师预期的18.01美元。然而，诊断实验室部门有机增长的短板成为拖累股价的主要因素，盖过了整体业绩向好的积极影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.